Cargando…
Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
BACKGROUND: The use of telmisartan (TEL), an angiotensin‐receptor blocker, for the control of systemic hypertension and proteinuria in dogs has not been reported extensively in a clinical setting. OBJECTIVES: To determine the effects of an angiotensin‐converting enzyme inhibitor (ACEi) alone, ACEi i...
Autores principales: | Fowler, Brittany L., Stefanovski, Darko, Hess, Rebecka S., McGonigle, Kathryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163128/ https://www.ncbi.nlm.nih.gov/pubmed/33769606 http://dx.doi.org/10.1111/jvim.16102 |
Ejemplares similares
-
Esophagostomy tube complications in dogs and cats: Retrospective review of 225 cases
por: Nathanson, Olivia, et al.
Publicado: (2019) -
Treatment of proteinuria in dogs with telmisartan: A retrospective study
por: Lecavalier, Julie, et al.
Publicado: (2021) -
Response and survival of dogs with proteinuria (UPC > 2.0) treated with angiotensin converting enzyme inhibitors
por: Fulton, Emily A., et al.
Publicado: (2023) -
Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020) -
Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double‐masked, randomized clinical trial
por: Lourenço, Bianca N., et al.
Publicado: (2020)